Literature DB >> 8438848

Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.

J Jankowski1, D Hopwood, R Pringle, K G Wormsley.   

Abstract

A 49-yr-old male was reviewed who had a 10-yr history of reflux esophagitis. He presented initially with frequent heartburn of moderate severity and, on subsequent endoscopy, was noted to have erosive esophagitis and, at that time, a high maximal gastric acid output. During the next 5 yr, his symptoms and acid output diminished. Eight years after presentation, he was noted to have developed a small area of Barrett's metaplasia, without dysplastic change. Ten years after the initial presentation he was completely asymptomatic, despite having extensive Barrett's metaplasia, now with high grade dysplasia. As a result, he was referred for esophagogastrectomy. At the time of surgery, he had alkaline reflux, with antacid gastric contents and, subsequently, hypochlorhydria was proven by a pentagastrin test. A second individual (male, 46 yr) who presented initially with reflux symptoms and gastric-type metaplasia, underwent gastric secretory studies that revealed a peak acid output of 16 mmol/L in 1986. During the period 1989 to 1991, his symptoms progressed despite H2 antagonist therapy. In this regard he was reinvestigated, and his peak acid output in 1991 was 0 mmol/L, and subsequent esophageal biopsies demonstrated intestinal metaplasia in four of six biopsies (two biopsies had high-grade dysplasia; the two others had gastric-type metaplasia). He has refused esophageal resection, and is being reviewed regularly at the endoscopy clinic. Flow cytometric analysis of the esophagus in both individuals revealed expression of epidermal growth factor receptor which was increased in the areas of high grade dysplasia, compared with Barrett's mucosa without dysplasia or normal cardiac mucosa. We conclude that alkaline reflux may accelerate the development of Barrett's esophagus (and intestinal type metaplasia) in patients with gastroesophageal reflux disease. The increased expressed of epidermal growth factor receptors in Barrett's mucosa with dysplasia compared with Barrett's mucosa without dysplasia may reflect the higher malignant potential of the former mucosa.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8438848

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  10 in total

1.  Barrett's oesophagus and proton pump inhibitors: a pathological perspective.

Authors:  N A Shepherd
Journal:  Gut       Date:  2000-02       Impact factor: 23.059

2.  Impact of the biliary diversion procedure on carcinogenesis in Barrett's esophagus surgically induced by duodenoesophageal reflux in rats.

Authors:  Koji Nishijima; Koichi Miwa; Tomoharu Miyashita; Shinichi Kinami; Itasu Ninomiya; Sachio Fushida; Takashi Fujimura; Takanori Hattori
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

3.  Reflux, Barrett's, and adenocarcinoma of the esophagus: can we disrupt the pathway?

Authors:  Steven R DeMeester
Journal:  J Gastrointest Surg       Date:  2010-01-22       Impact factor: 3.452

4.  Increase of epidermal growth factor receptor expression in progression of GERD, Barrett, and adenocarcinoma of esophagus.

Authors:  Guilherme Pretto; Richard Ricachenevsky Gurski; Marcelo Binato; Daniel Navarini; Wolfgan William Schmidt Aguiar; Luise Meurer
Journal:  Dig Dis Sci       Date:  2012-08-09       Impact factor: 3.199

5.  Gene expression in Barrett's mucosa: acute and chronic adaptive responses in the oesophagus.

Authors:  J Jankowski
Journal:  Gut       Date:  1993-12       Impact factor: 23.059

6.  Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery.

Authors:  J A Salo; J T Salminen; T A Kiviluoto; A T Nemlander; O J Rämö; M A Färkkilä; E O Kivilaakso; S P Mattila
Journal:  Ann Surg       Date:  1998-01       Impact factor: 12.969

7.  Chronic treatment with epidermal growth factor causes esophageal epithelial hyperplasia in pigs and rats.

Authors:  C O Juhl; L Vinter-Jensen; S S Poulsen; T F Orntoft; E Z Dajani
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

8.  Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett's esophagus to adenocarcinoma.

Authors:  Yan Li; John M Wo; Mukunda B Ray; Whitney Jones; Ruifeng R Su; Susan Ellis; Robert C G Martin
Journal:  World J Gastroenterol       Date:  2006-02-14       Impact factor: 5.742

Review 9.  Chemoprevention in Barrett's esophagus.

Authors:  Sumera Ilyas; Cathrine J DeMars; Navtej S Buttar
Journal:  J Gastrointest Cancer       Date:  2007

10.  Intramucosal distribution of WNT signaling components in human esophagus.

Authors:  Irshad Ali; Parvaneh Rafiee; Yue Zheng; Christopher Johnson; Banani Banerjee; George Haasler; Howard Jacob; Reza Shaker
Journal:  J Clin Gastroenterol       Date:  2009-04       Impact factor: 3.062

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.